CBU
TMO icon

CIBC Bank USA’s Thermo Fisher Scientific TMO Stock Holding History

CIBC Bank USA’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.12M Buy
3,447
+110
+3% +$33.4K 0.15% 93
2019
Q3 		$972K Buy
3,337
+186
+6% +$53.3K 0.14% 96
2019
Q2 		$926K Sell
3,151
-454
-13% -$125K 0.13% 93
2019
Q1 		$987K Sell
3,605
-540
-13% -$134K 0.14% 79
2018
Q4 		$928K Sell
4,145
-288
-6% -$67.6K 0.15% 83
2018
Q3 		$1.08M Buy
4,433
+163
+4% +$37.5K 0.15% 81
2018
Q2 		$884K Sell
4,270
-72
-2% -$15.3K 0.12% 93
2018
Q1 		$897K Sell
4,342
-108
-2% -$22.7K 0.12% 96
2017
Q4 		$845K Buy
4,450
+16
+0.4% +$3.06K 0.11% 108
2017
Q3 		$839K Sell
4,434
-366
-8% -$66.3K 0.11% 103
2017
Q2 		$837K Buy
4,800
+1,127
+31% +$189K 0.11% 95
2017
Q1 		$564K Buy
3,673
+525
+17% +$80.2K 0.08% 133
2016
Q4 		$444K Hold
3,148
– – 0.06% 159
2016
Q3 		$500K Hold
3,148
– – 0.08% 149
2016
Q2 		$465K Buy
3,148
+83
+3% +$12.3K 0.07% 151
2016
Q1 		$434K Sell
3,065
-3,475
-53% -$466K 0.08% 147
2015
Q4 		$927K Buy
6,540
+4
+0.1% +$534 0.16% 88
2015
Q3 		$799K Sell
6,536
-794
-11% -$103K 0.15% 91
2015
Q2 		$952K Sell
7,330
-200
-3% -$26.1K 0.16% 91
2015
Q1 		$1.01M Sell
7,530
-2,425
-24% -$313K 0.18% 81
2014
Q4 		$1.25M Buy
9,955
+3,375
+51% +$410K 0.22% 75
2014
Q3 		$801K Sell
6,580
-78
-1% -$9.48K 0.16% 110
2014
Q2 		$786K Hold
6,658
– – 0.15% 114
2014
Q1 		$801K Sell
6,658
-225
-3% -$26.8K 0.17% 110
2013
Q4 		$767K Buy
6,883
+923
+15% +$91.8K 0.17% 131
2013
Q3 		$549K Sell
5,960
-9,915
-62% -$897K 0.13% 166
2013
Q2 		$1.34M Buy
+15,875
New +$1.32M 0.08% 165

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIBC Bank USA's TMO Position: Q4 2019 in Review

CIBC Bank USA increased its Thermo Fisher Scientific (TMO) stake by 3.3% in Q4 2019, buying an estimated $33.4K and bringing the position to 3,447 shares worth $1.12M. The position accounts for 0.15% of the portfolio, ranked #93.

CIBC Bank USA first reported a position in TMO in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.34M in Q2 2013. 1,678 funds tracked by Wall St. Rank hold TMO as of Q4 2019.

  • CIBC Bank USA held 3,447 shares of Thermo Fisher Scientific worth $1.12M as of Q4 2019.
  • CIBC Bank USA bought 110 Thermo Fisher Scientific shares in Q4 2019, an estimated $33.4K.
  • Thermo Fisher Scientific made up 0.15% of CIBC Bank USA's portfolio in Q4 2019, its #93 holding.
  • CIBC Bank USA first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 27 quarters since.
  • CIBC Bank USA's Thermo Fisher Scientific position peaked at $1.34M in Q2 2013.
  • 1,678 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.